Auris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial Results
April 16, 2020 07:00 ET
|
Auris Medical AG
Phase 1b trial with intranasal betahistine for prevention of antipsychotic-induced weight gain progressing towards final read-outPhase 2 trial with intranasal betahistine for treatment of acute...
Tecnoglass Sets Date for Third Quarter 2019 Earnings Release and Conference Call
October 08, 2019 07:00 ET
|
Tecnoglass Inc.
Barranquilla, Colombia, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Tecnoglass Inc. (NASDAQ: TGLS) ("Tecnoglass" or the "Company"), a leading manufacturer of architectural glass, windows, and associated...